These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus. Crockett SE, Mazzaferri EL, Cataland S. Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601 [Abstract] [Full Text] [Related]
6. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus. Elahi D, Andersen DK, Muller DC, Tobin JD, Brown JC, Andres R. Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904 [Abstract] [Full Text] [Related]
7. Effect of GIP on insulin release to intravenous glucose infusion in hyperthyroid rats. Müller MK, Hellwig J, Schäfer A, Goebell H, Brown JC. Horm Metab Res; 1986 Mar; 18(3):163-6. PubMed ID: 3516833 [Abstract] [Full Text] [Related]
8. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man. Falko JM, Crockett SE, Cataland S, O'Dorisio TM, Kramer W, Mazzaferri EL. Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042 [Abstract] [Full Text] [Related]
11. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function. Verdonk CA, Rizza RA, Nelson RL, Go VL, Gerich JE, Service FJ. J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457 [Abstract] [Full Text] [Related]
14. [Insulin, glucagon and growth hormone responses during glucose, arginine and insulin tolerance tests in children with hyperthyroidism]. Kato T, Matsuura N, Fujita H, Fujieda K, Nohara Y, Mikami Y, Abe K, Fukushima N. Nihon Naibunpi Gakkai Zasshi; 1985 Jun 20; 61(6):665-76. PubMed ID: 3902521 [Abstract] [Full Text] [Related]
15. Hyperinsulinism, glucose-dependent insulinotropic polypeptide, and the enteroinsular axis in morbidly obese patients before and after gastric bypass. Sirinek KR, O'Dorisio TM, Hill D, McFee AS. Surgery; 1986 Oct 20; 100(4):781-7. PubMed ID: 3532392 [Abstract] [Full Text] [Related]
16. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8. Nauck M, Schmidt WE, Ebert R, Strietzel J, Cantor P, Hoffmann G, Creutzfeldt W. J Clin Endocrinol Metab; 1989 Sep 20; 69(3):654-62. PubMed ID: 2668324 [Abstract] [Full Text] [Related]
17. Effects of gastric inhibitory polypeptide in the response to prolonged parenteral or enteral alimentation in rats. Baer AR, Dupre J. Diabetes; 1985 Nov 20; 34(11):1108-12. PubMed ID: 3930323 [Abstract] [Full Text] [Related]
18. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon. Ebert R, Arnold R, Creutzfeldt W. Gut; 1977 Feb 20; 18(2):121-7. PubMed ID: 856672 [Abstract] [Full Text] [Related]